LTPM CHINA
A Pharma Machinery Division,For A Better Life
News Group
Industry news
IMPORTANCE OF MIXINGMixing is at the heart of most production systems in the chemical process industry, pharmaceutical industry, food industry, and allied industries. It is of vital importance in processing solids, liquids, and gases in the polymer, glass, ceramics, building materials, pulp and paper, petroleum, and power industries and in industrial waste treatment systems.Nov 13,2019- What are CGMPs?CGMP refers to the Current Good Manufacturing Practice regulations enforced by the FDA.Nov 8,2019
- The Significance of Humidity Control in GMP Compliant ProductionThe Significance of Humidity Control in GMP Compliant ProductionNov 4,2019
- Oral Solid Dosage Pharmaceutical Formulation Market is Anticipated to Collect of US$ 926.3 Bn by 2027Oral Solid Dosage Pharmaceutical Formulation Market is Anticipated to Collect of US$ 926.3 Bn by 2027Oct 18,2019
- Solid Dosage Manufacturing Opportunities abound for solid dose CMOsSolid Dosage Manufacturing Opportunities abound for solid dose CMOsOct 17,2019
- The sales team of LTPM China in CPhI Shanghai 2019The sales team of LTPM China in CPhI Shanghai 2019Aug 27,2019
- Graco Announces Complete Line of SaniForce 2.0 EquipmentGraco Announces Complete Line of SaniForce 2.0 EquipmentJul 15,2019
- Bipartisan Bill Will Strengthen Patent Rights and Protect U.S. Leadership in Biotechnology InnovationBipartisan Bill Will Strengthen Patent Rights and Protect U.S. Leadership in Biotechnology InnovationJul 11,2019
- Walgreens Boots Alliance Increases Quarterly DividendWalgreens Boots Alliance Increases Quarterly DividendJul 11,2019
- Global Psoriatic Arthritis Market Spotlight 2019-2029 – ResearchAndMarkets.comDUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Psoriatic Arthritis” report has been added to ResearchAndMarkets.com’s offering.Jul 1,2019
- Pfizer Presents Initial Clinical Data on Phase 1b Gene Therapy Study for Duchenne Muscular Dystrophy (DMD)Gene Therapy Study for Duchenne Muscular Dystrophy (DMD)Jul 1,2019
- vTv Therapeutics Initiates Phase 2 Clinical Trial Evaluating Azeliragon in Patients with Mild Alzheimer’s Disease and Type 2 DiabetesHIGH POINT, N.C.–(BUSINESS WIRE)–vTv Therapeutics Inc. (Nasdaq: VTVT) announced today that the first patient has been screened for the phase 2 proof of concept study evaluating the safety and efficacy of azeliragon in patients with mild Alzheimer’s disease and type 2 diabetes.Jun 28,2019
- Columbia Care Enters World’s Largest Regulated Cannabis Market with Grand Opening of Flagship Dispensary in San Diego, CaliforniaGlobal medical cannabis leader launches west coast expansion plan in California’s largest, limited license metropolitan marketJun 28,2019
- Exicure Announces Preclinical Data Supporting Development of SNA Technology in the Central Nervous SystemExicure Announces Preclinical Data Supporting Development of SNA Technology in the Central Nervous SystemJun 27,2019
- Rebiotix Leaders to Discuss Microbiome Product Development Challenges and Regulation at Microbiome Movement – Drug Development Summit 2019Rebiotix Leaders to Discuss Microbiome Product Development Challenges and Regulation at Microbiome Movement – Drug Development Summit 2019Jun 27,2019
Please send your message to us
- Tel
- *Title
- *Content
CONTACT US
subscription